Twitter LinkedIn
    Monday, May 23
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Funds»Leukocare secures $17.5m in funding round led by Petrichor
    Funds

    Leukocare secures $17.5m in funding round led by Petrichor

    June 23, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Medicine doctor hand working with modern computer interface as medical concept
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Leukocare AG, a biotechnology company specialised in the field of biopharmaceutical formulation development, has closed a USD17.5 million (EUR 14.6 million) financing, led by Petrichor Healthcare Capital Management, with participation from existing Leukocare shareholders. 

    The financing consists of a USD15 million convertible loan and a USD2.5 million equity investment from Petrichor. Proceeds will be used to accelerate Leukocare’s US expansion activities, bolster the company’s expertise in the fields of viral vector and vaccine formulation, as well as the emerging field of mRNA formulation, and to expand the Company’s suite of bioinformatics capabilities.

    Michael Scholl, Chief Executive Officer at Leukocare, says: “We are thrilled about the completion of this financing round. Our vast expertise in formulation development of biopharmaceuticals and viral vectors in combination with innovative bioinformatics puts us at the forefront of drug product development in these fields. This funding enables us to expedite our growth plans which encompass enhancing our bioinformatics capabilities as well as growing Leukocare´s market presence in the US. I would like to thank our new investor Petrichor and our existing shareholders for their continuous support and trust.”

    Read more/Source: Private Equity Wire

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Deals Transactions funds Healthcare & Life Sciences Investments peinsider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Vista Equity Partners Among the First Major U.S. Private Equity Firms to Advance Global ESG Strategy with Portfolio-Wide Participation in Climate Program

    May 23, 2022

    General Atlantic eyeing $2 bn investment in India, SE Asia

    May 23, 2022

    Software firm SpotOn valued at $3.6bn after Dragoneer-led funding round

    May 23, 2022

    Blackstone Credit Acquires 49% Interest in U.S. East Coast LNG Infrastructure Asset

    May 23, 2022

    Comments are closed.

    Other Articles

    Wheelhouse Advisors secures additional investment to support growth plans

    June 22, 2021

    Exclusive: S.African upstart bank teams up with JG Summit to expand into Philippines

    February 23, 2021

    EQT Growth leads EUR235m Mambu Series E round at EUR4.9bn valuation

    December 9, 2021

    Procuritas portfolio company DSI makes two substantial add-on acquisitions

    June 1, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?